• Two Decades of Toremifene: Advances in Breast Cancer Endocri

  2026-06-09

  This review synthesizes 20 years of clinical experience with toremifene, a selective estrogen receptor modulator (SERM), in the treatment of breast cancer. The paper provides key insights into the pharmacological rationale, efficacy, and safety profile of toremifene, highlighting its role within personalized medicine and biomarker-driven therapeutic strategies.

• Laminin (925-933): Technical Guide for Cell Adhesion Assays

  2026-06-09

  Laminin (925-933) is a synthetic peptide derived from the laminin B1 chain, optimized for cell adhesion and chemotaxis assays in extracellular matrix research. It addresses the need for defined, receptor-specific tools to dissect cell migration and basement membrane interactions. Not for diagnostic or in vivo therapeutic use; applicability is limited to scientific research contexts.

• 6-Thioguanine Blocks EV71 by Targeting BIRC3-Mediated Autoph

  2026-06-08

  This study reveals that 6-thioguanine (6-TG), an established antineoplastic agent, potently inhibits Enterovirus 71 (EV71) replication in vitro by disrupting BIRC3-mediated autophagy. These findings provide mechanistic insight and a foundation for potential therapeutic development against EV71-related hand, foot, and mouth disease.

• Salmonella Haem Biosynthesis Undermines Macrophage Defense

  2026-06-08

  This study uncovers a mechanism by which Salmonella Typhimurium boosts its haem production to evade macrophage phagocytosis, thereby enhancing its virulence in mice. The findings reveal that methyltransferase-mediated modification of haem biosynthetic enzymes is central to immune evasion, providing new avenues for infection biology and heme pathway research.

• Astrocytic GAT-3 Shapes Synaptic Transmission in Dentate Gyr

  2026-06-07

  This study reveals that astrocytic GAT-3 modulates synaptic transmission and memory formation within the dentate gyrus by regulating intracellular calcium and presynaptic receptor activity. The findings clarify a key glial-neuronal mechanism underpinning cognitive processing and offer new directions for targeted synaptic transmission research.

• Bufalin as a Precision Tool: Mechanistic Insights for Oncolo

  2026-06-06

  Explore how Bufalin, a cardiotonic steroid, enables precision targeting in cancer research. This article delivers a unique mechanistic analysis and practical guidance for translational oncology workflows.

• Cytoskeleton-Dependent Mechanotransduction in Autophagy

  2026-06-05

  Liu et al. (2024) provide direct evidence that the cytoskeleton, especially microfilaments, is essential for the induction of autophagy by mechanical stress in human cells. This mechanistic insight refines our understanding of how cells translate physical forces into autophagic signaling, with significant implications for designing targeted assays in cancer and cell biology research.

• HDAC Inhibition Reverses EBV-Induced Dedifferentiation in NP

  2026-06-05

  This study uncovers how HDAC inhibition can reverse Epstein-Barr virus (EBV)-driven dedifferentiation in nasopharyngeal carcinoma (NPC) by restoring CEBPA expression, thus reducing cancer cell plasticity. The findings offer a mechanistic framework for differentiation therapy in solid tumors and highlight the importance of targeting epigenetic regulators to overcome therapeutic resistance.

• Verteporfin in Photodynamic Therapy: Protocols and Innovatio

  2026-06-04

  Verteporfin (CL 318952) stands out in photodynamic therapy and autophagy research with dual-action versatility. This article unpacks stepwise protocols, advanced applications, and troubleshooting strategies—backed by recent mechanobiology insights—to ensure high-reproducibility outcomes in both ocular and oncology models.

• Surface Chemistry of Magnetite-CNCs Enables Safe Magnetic Hy

  2026-06-04

  Hasan et al. systematically dissect how surface modifications of cellulose nanocrystals (CNCs) direct the assembly and functional properties of magnetite-CNC nanocomposites. Their findings establish key structure–property relationships, confirming the biocompatibility and potential of these materials for magnetic hyperthermia applications.

• Practical Guide to 740 Y-P: Protocols for PI 3-Kinase Activa

  2026-06-03

  740 Y-P is a potent, cell-permeable PI 3-kinase activator for modulating the PI3K/AKT signaling pathway in cellular and biochemical models. It is best suited for applications in vesicular trafficking research, neuronal cell survival, and apoptosis assays where precise pathway activation is required. This reagent is not appropriate where PI3K inhibition or uncharacterized off-target effects are a concern.

• Pharmacokinetics and Clinical Rationale of Cefazedone in CAP

  2026-06-03

  This study provides the first detailed PK/PD evaluation of intravenous cefazedone (Refosporen) for mild to moderate community-acquired pneumonia (CAP), establishing that the standard 2 g q12h regimen achieves clinically meaningful time above MIC and high cure rates against susceptible bacteria. Its findings clarify optimal dosing and reinforce cefazedone’s role in targeted antibacterial therapy.

• Cycloheximide in Protein Turnover: Precision Kinetics & Fibr

  2026-06-02

  Explore cutting-edge applications of Cycloheximide as a protein biosynthesis inhibitor, with deep insights into kinetic degradation assays and translational control in fibrosis research. Distinct from prior articles, this piece bridges advanced methodology with practical protocol guidance.

• Indometacin Sodium Inhibits PSC Activation via COX-2 Downreg

  2026-06-02

  This study demonstrates that indometacin sodium effectively inhibits human pancreatic stellate cell (PSC) proliferation and activation by suppressing COX-2 expression. The findings highlight a mechanistic basis for targeting PSCs in pancreatic ductal adenocarcinoma (PDAC) stroma and provide protocol-relevant insights for anti-inflammatory and cancer microenvironment research.

• Midecamycin: Mechanistic Insights and Assay Strategy Innovat

  2026-06-01

  Explore how midecamycin, a 16-membered acetoxy-substituted macrolide antibiotic, uniquely inhibits Gram-positive bacteria and informs advanced antibacterial assay design. This article offers mechanistic depth and practical protocol innovations not covered in prior reviews.

15421 records 1/1029 page Next 12345 下5页 Last page